During the past decade, Retina Associates of South Texas conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Associates of South Texas" #1 sponsor was "Apellis Pharmaceuticals, Inc." with 2 trials, followed by "Allergan" with 1 trials sponsored, "Amgen" with 1 trials sponsored, "Clearside Biomedical, Inc." with 1 trials sponsored and "Lpath, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Associates of South Texas" #1 collaborator was "MEDARVA Foundation" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Retina Associates of South Texas" are "Geographic Atrophy" (2 trials), "Diabetes Mellitus" (1 trials), "Diabetic Macular Edema" (1 trials), "Diabetic Retinopathy" (1 trials) and "Exudative Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Retina Associates of South Texas" in a lesser frequency.

Most popular intervention types in "Retina Associates of South Texas" are "Drug" (8 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (2 trials), "0.5 mg Lucentis or 1.25 mg Avastin or 2 mg Eylea" (1 trials), "0.5 mg iSONEP" (1 trials), "4.0 mg iSONEP" (1 trials) and "ABP 938" (1 trials). Other intervention names were less common.

The vast majority of trials in "Retina Associates of South Texas" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Retina Associates of South Texas". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Retina Associates of South Texas, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Associates of South Texas, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".